title: [Childhood obesity. Recommendations of the Nutrition Committee of the Spanish Association of Pediatrics. Part II. Diagnosis. Comorbidities. Treatment].
abstract: The present article reviews the diagnostic criteria for pediatric obesity and its comorbidities. Treatment is also reviewed, including promotion of physical activity, and dietetic, pharmacologic and surgical treatment.
authors.affiliation: Unidad de Nutrición y Metabolopatías, Hospital Infantil La Fe, Valencia, España.
authors.forename: J
authors.initials: J
authors.lastname: Dalmau Serra
authors.forename: M
authors.initials: M
authors.lastname: Alonso Franch
authors.forename: L
authors.initials: L
authors.lastname: Gómez López
authors.forename: C
authors.initials: C
authors.lastname: Martínez Costa
authors.forename: C
authors.initials: C
authors.lastname: Sierra Salinas
mesh_terms: D019440:Anti-Obesity Agents / Q000627:therapeutic use; D001067:Appetite Depressants / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D002648:Child; D003131:Combined Modality Therapy; D003503:Cyclobutanes / Q000627:therapeutic use; D005234:Fatty Liver / Q000453:epidemiology*; D015390:Gastric Bypass; D006801:Humans; D006937:Hypercholesterolemia / Q000453:epidemiology*; D006973:Hypertension / Q000453:epidemiology*; D007333:Insulin Resistance; D007783:Lactones / Q000627:therapeutic use; D024821:Metabolic Syndrome / Q000453:epidemiology*; D009765:Obesity / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D000077403:Orlistat; D012307:Risk Factors
chemical_list: D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D007783:Lactones; D000077403:Orlistat; C058254:sibutramine